Phase II Randomized Trial Evaluating Neoadjuvant Therapy With Neratinib and/or Trastuzumab Followed by Postoperative Trastuzumab in Women With Locally Advanced HER2-positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Paclitaxel|DRUG: Trastuzumab|DRUG: Neratinib|DRUG: Doxorubicin|DRUG: Cyclophosphamide
Sponsor: NSABP Foundation Inc
Collaborators: Puma Biotechnology, Inc.